The use of tiagabine in affective disorders

Pharmacopsychiatry

Volumn 35, Issue 1, 2002, Pages 33-34

  Carta, Mauro G ^a   Hardoy, M C ^a   Grunze, H ^b   Carpiniello, B ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; TIAGABINE;

AFFECTIVE NEUROSIS; CLINICAL TRIAL; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG TOLERABILITY; EPILEPSY; HUMAN; LONG TERM CARE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; NEUROTOXICITY; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT OUTCOME; TREATMENT PLANNING;

ANTICONVULSANTS; BIPOLAR DISORDER; HUMANS; MOOD DISORDERS; NIPECOTIC ACIDS;

EID: 0036167550     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-19836     Document Type: Short Survey

References (9)

1. Basic mechanisms of gabitril (tiagabine) and future potential developments
2. A review of the preclinical pharmacology of tiagabine: A potent and selective anticonvulsant GABA uptake inhibitor
3. Tiagabine a review of its pharmacodynamic and pharmacokinetic properties and terapeutic potential in the management of epilepsy
4. Review of controlled trials of gabitril (tiagabine): A clinician's viewpoint
5. Beneficial results of tiagabine therapy in patients with psychiatric history
6. Tiagabine the safety landscape
7. Tiagabine appears not to be efficacious in the treatment of acute mania
8. Tiagabine and the treatment of refractory bipolar disorder
9. Adjunctive tiagabine treatment of psychiatric disorders: Three cases